CADL

NASDAQ · Biotechnology

Candel Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.97

+0.06 (+1.22%)

As of Mar 22, 10:28 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +857.5% upside

Low Target $33.44

Average Target $47.59

High Target $47.92

Current Price $4.97

Current
$4.97

Target
$47.59

$33.44 $47.59 avg $47.92

Scenario Analysis

Bear Case

$33.44

572.8%

Low target

Base Case

$47.59

+857.5%

Avg target

Bull Case

$47.92

+864.2%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$43.60

-88.6% from high

52-Week Low

$28.51

+-82.6% from low

Target vs 52W High

$47.59

+9.2% vs high

Next Earnings Report

Mar 26, 2026

Today

Earnings in today. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%